---
category: news
title: "Gene Therapy to Target PD-L1 for Oncology by Marino Biotechnology for Lymphoma: Likelihood of Approval"
excerpt: "Gene Therapy to Target PD-L1 for Oncology is under clinical development by Marino Biotechnology and currently in Phase I for Lymphoma."
publishedDateTime: 2024-02-19T18:05:00Z
originalUrl: "https://www.pharmaceutical-technology.com/data-insights/gene-therapy-to-target-pd-l1-for-oncology-marino-biotechnology-lymphoma-likelihood-of-approval/"
webUrl: "https://www.pharmaceutical-technology.com/data-insights/gene-therapy-to-target-pd-l1-for-oncology-marino-biotechnology-lymphoma-likelihood-of-approval/"
type: article
quality: 3
heat: 3
published: false

provider:
  name: Pharmaceutical Technology
  domain: pharmaceutical-technology.com

topics:
  - AI in Healthcare
  - AI

secured: "/VcxYfB+qfUPTUBIPfoRUAPQQ7Px2sV5Pxa+ix1fx4A+VuSXa8+z1Hqi26odGY+nFbmUL6cDjqEcwrUF26X6y9FWAL1YcFZ33TsuWu5jCikya5TKvogEWID3F2VRT0AB7vFlVhTr7AP/q8BlDXZxpbAhzqzwCAgjXf1hBUT/dP48FZcbXBzKfyJQ21a4wuNdRPWH7p+VvT8XnQTNgNvvxEKa51rms+XdM9NjX59P/3TNu2kn0p91lphzN/Kh35Y9SdHjzUfaFExWwdWC0hRBiR0FE1o2KWykyb8WYq2EuIw0dayoAzjzPk7wvleSH+Ehu1aZ+oM9L/I9kII1teSzhY9t2KUN7HWNK4WxwuzTLdU=;by2LLVlhmQP5hOMB4Gsubg=="
---

